Emcure Pharmaceuticals Revenue vs. Operating Margin
| EMCURE Stock | 1,373 16.15 1.16% |
For Emcure Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Emcure Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Emcure Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Emcure Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Emcure Pharmaceuticals over time as well as its relative position and ranking within its peers.
Emcure |
Emcure Pharmaceuticals Operating Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Emcure Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Emcure Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Emcure Pharmaceuticals is rated below average in revenue category among its peers. It also is rated below average in operating margin category among its peers . The ratio of Revenue to Operating Margin for Emcure Pharmaceuticals is about 517,369,283,111 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Emcure Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emcure Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Emcure Revenue vs. Competition
Emcure Pharmaceuticals is rated below average in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 309.08 Billion. Emcure Pharmaceuticals totals roughly 69.17 Billion in revenue claiming about 22% of equities under Drug Manufacturers - Specialty & Generic industry.
Emcure Operating Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Emcure Pharmaceuticals |
| = | 69.17 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Emcure Pharmaceuticals |
| = | 0.13 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Emcure Operating Margin Comparison
Emcure Pharmaceuticals is rated below average in operating margin category among its peers.
Emcure Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Emcure Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Emcure Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Emcure Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Emcure Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Emcure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Emcure Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Emcure Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Emcure Pharmaceuticals' important profitability drivers and their relationship over time.
Use Emcure Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emcure Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Emcure Pharmaceuticals Pair Trading
Emcure Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Emcure Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emcure Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emcure Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emcure Pharmaceuticals to buy it.
The correlation of Emcure Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emcure Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emcure Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emcure Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Emcure Pharmaceuticals position
In addition to having Emcure Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hedge Favorites Thematic Idea Now
Hedge Favorites
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Emcure Stock
To fully project Emcure Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Emcure Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Emcure Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.